Loading…
Drugs, therapies, antibodies, gene and cell technology.
Part of Deep tech & other
By region: North America 125 · Europe 31 · China 11 · Other regions 8 · Korea 8 · Asia 6 · Japan 3
Alpha-1 antitrypsin gene editing.
AI protein / programmable bioengineering.
Biotech developing iPS-cell-derived oocyte and ovarian somatic cells for fertility treatment (pipelines DIOS-001 and DIOS-101).
Insect-based ingredients for animal and plant nutrition.
Turns idle breweries into alternative protein factories.
Automates drug discovery.
AI for drug discovery.
Cancer diagnostics.
Turns routine blood and cytology imaging into genomic insights for hematology labs.
Transport technology for living cells.
Industrial-grade embodied robots.
AI drug safety.
Stem/progenitor cell therapies for lung and kidney disease.
Pharma manufacturing
Operating system for AI-ready labs.
Modernises chemical production.
Immunology drug development.
AI plus rapid-experiment platform (Orchard) to discover gene-editing targets and design plant traits for crops.
Self-driving lab for drug discovery (AI for science).
Pet drug evaluation services.
GLP-1 drugs licensed from Hengrui.
RNAx platform: an mRNA-encoded protein that dampens innate immune response to make RNA vaccines more tolerable.
Nonprofit that funds and conducts connectomics research to accelerate human mind emulation.
XGenomes is building the sequencing technology of the future.
YourChoice therapeutics is revolutionizing the contraceptive market…
A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
Discovering bispecific antibody drug-conjugates (BsADC) against cancer
Breakthrough medicines unlocking the biology of heme
We use human data and AI to develop better drugs faster.
Unlocking the utility of genomics for the world.
Extrapolative AI to unlock First-in-Class drugs
Agentic AI platform for Pharma GTM teams
Discovering drugs that target the DNA regulome
Tradewind translates scientific insight into innovative ways of…
Transforming pharmacies in the UK into diagnostic centers
Delivering RNA therapies.
AI Automation for Therapy Practices
Multimodal foundation models to predict uncollected patient biology
Full Stack Pharmaceutical Company for Personalized Peptides and GLP-1s
Growing micro-organs to find new drugs
Regulating the immune system to block cancer & autoimmune diseases
Unlocking the next generation of mRNA medicines
Discovering the true signals of disease to power life-changing drugs.
Genetic Medicine with Small Molecules
Shiru leverages ML to create proteins to feed the world sustainably.
A therapeutics platform for curing inflammatory disorders
Your biopharma team, from molecule design to portfolio strategy
mRNA therapeutics to extend healthspan entering clinical trials
Platform injectable gel based therapeutic for osteoarthritis
Rev is a biotechnology company creating better plants.